By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptive Biotechnologies 

307 Westlake Avenue N
Suite 300
Seattle  Washington  98109  U.S.A.
Phone: 206-659-0067 Fax: 206-659-0667



Company News
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees 5/21/2015 6:31:28 AM
Adaptive Biotech' immunoSEQ Assay Provides Groundbreaking Insight Into T-Cell Fate, Significantly Advancing Understanding Of Adaptive Immunity 5/12/2015 10:11:04 AM
Adaptive Biotech And Collaborators To Present 5 Studies Demonstrating Utility Of Immunosequencing To Determine T-Cell Function In Chronic And Infectious Diseases At The 2015 American Association Of Immunologists Annual Meeting 5/8/2015 11:26:33 AM
Adaptive Biotech Bags $195 Million In Largest Washington Fundraise This Year 5/6/2015 7:01:55 AM
Adaptive Biotechnologies And Researchers From MD Anderson Cancer Center Demonstrate Ability To Detect Hodgkin's Lymphoma In Blood 4/28/2015 7:44:54 AM
Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Detects Relapse With Higher Specificity Than PET/CT In Diffuse Large B-Cell Lymphoma Patients 4/22/2015 11:20:18 AM
Adaptive Biotechnologies And Collaborators To Present 4 Studies Demonstrating Clinical Relevance Of Immunosequencing In The Treatment Of Solid Tumors At The 2015 American Association for Cancer Research Annual Meeting 4/15/2015 8:17:00 AM
Multiple Myeloma Research Foundation (MMRF), University Of Torino, And Adaptive Biotechnologies Work To Speed Novel Minimal Residual Disease Monitoring Technologies To Patients 4/14/2015 8:06:11 AM
Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse In Diffuse Large B-Cell Lymphoma Patients By Sensitively Detecting Circulating Tumor DNA 4/2/2015 6:37:54 AM
Adaptive Biotechnologies Invited To Present At Upcoming Conferences 3/17/2015 11:09:39 AM